ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,900.29
      0.01%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Andrx (ADRX)

      7. Andrx (ADRX) News

      ADRX

      Andrx (ADRX)

      Andrx
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ADRX
      DateTimeSourceHeadlineSymbolCompany
      10/31/20064:02PMPR Newswire (US)Watson Receives FTC Clearance for Andrx AcquisitionNASDAQ:ADRXAndrx
      10/18/20069:05AMPR Newswire (US)Watson Certifies Substantial Compliance With FTC Second RequestNASDAQ:ADRXAndrx
      09/13/20067:30AMBusiness WireAndrx Certifies to the Satisfaction of Certain Conditions to Closing Acquisition by WatsonNASDAQ:ADRXAndrx
      08/08/20066:06PMBusiness WireAndrx Corporation Reports Financial Results for 2006 Second QuarterNASDAQ:ADRXAndrx
      08/01/20068:00AMBusiness WireAndrx to Issue Financial Results for 2006 Second QuarterNASDAQ:ADRXAndrx
      05/04/20065:28PMBusiness WireAndrx Corporation Reports Financial Results for 2006 First QuarterNASDAQ:ADRXAndrx
      05/03/20067:00AMPR Newswire (US)Watson Pharmaceuticals and Andrx Corporation Receive FTC Second RequestNASDAQ:ADRXAndrx
      04/26/200612:16PMBusiness WireAndrx to Issue Financial Results for 2006 First Quarter and Host Conference CallNASDAQ:ADRXAndrx
      04/04/20067:58AMBusiness WireAndrx Announces Filing of NDA by Takeda for ACTOS and Extended-Release Metformin Combination ProductNASDAQ:ADRXAndrx
      03/16/20064:09PMBusiness WireAndrx Corporation Reports Financial Results for 2005 Fourth Quarter and Full YearNASDAQ:ADRXAndrx
      03/13/20062:58PMBusiness WireAndrx to Issue Financial Results for 2005 Fourth Quarter and Full Year and Host Conference CallNASDAQ:ADRXAndrx
      03/13/20067:00AMPR Newswire (US)Watson to Acquire Andrx For $1.9 Billion, Creating the Third Largest Specialty Pharmaceutical Company In the U.S.NASDAQ:ADRXAndrx
      03/13/20067:00AMBusiness WireAndrx to Be Acquired by Watson for $25.00 Per Share; Total Transaction Valued at Approximately $1.9 BillionNASDAQ:ADRXAndrx
      02/02/20062:18PMBusiness WireAndrx to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device ConferenceNASDAQ:ADRXAndrx
      01/23/200612:20PMBusiness WireAndrx Announces Commercialization Agreement with InvaGenNASDAQ:ADRXAndrx
      01/18/20068:00AMBusiness WireAndrx Granted Summary Judgment for Generic Toprol-XLNASDAQ:ADRXAndrx
      11/11/20058:00AMBusiness WireAndrx Comments On Clarithromycin ER Preliminary InjunctionNASDAQ:ADRXAndrx
      11/07/20055:09PMBusiness WireAndrx Corporation Reports 2005 Third Quarter ResultsNASDAQ:ADRXAndrx
      11/04/20053:37PMBusiness WireAndrx to Present at CIBC World Markets Healthcare ConferenceNASDAQ:ADRXAndrx
      11/02/20052:20PMBusiness WireStull, Stull & Brody Announces Class Action on Behalf of Shareholders of Andrx Corp.NASDAQ:ADRXAndrx
      11/02/200510:16AMBusiness WireAndrx to Issue 2005 Third Quarter Financial Results and Host Conference CallNASDAQ:ADRXAndrx
      10/26/20053:36PMBusiness WireAndrx Resumes Full Operations Post-Hurricane WilmaNASDAQ:ADRXAndrx
      10/19/200510:48AMBusiness WireAndrx Announces ANDA Filing for Cardizem LANASDAQ:ADRXAndrx
      10/18/20057:12PMPR Newswire (US)Federman & Sherwood Announces That a Securities Class Action Lawsuit Was Filed Against Andrx CorporationNASDAQ:ADRXAndrx
      09/23/20058:47AMBusiness WireAndrx to Present at UBS Global Life Sciences ConferenceNASDAQ:ADRXAndrx
      09/20/20052:00PMBusiness WireAndrx Announces Change in Chief Financial OfficerNASDAQ:ADRXAndrx
      09/16/20059:01AMBusiness WireAndrx Appoints Robert I. Goldfarb Senior Vice President, General Counsel and SecretaryNASDAQ:ADRXAndrx
      09/09/20059:05AMBusiness WireAndrx to Present at Bear Stearns Annual Healthcare ConferenceNASDAQ:ADRXAndrx
      09/06/20059:31AMBusiness WireAndrx Reports on FDA DevelopmentsNASDAQ:ADRXAndrx
      07/18/20054:15PMBusiness WireAndrx to Issue 2005 Second Quarter Financial Results and Host Conference CallNASDAQ:ADRXAndrx
       Showing the most relevant articles for your search:NASDAQ:ADRX